Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -932 | N/A | N/A | N/A | N/A |
| Depreciation Amortization | 1 | N/A | N/A | N/A | N/A |
| Other Working Capital | 17 | N/A | N/A | N/A | N/A |
| Other Operating Activity | 463 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-451 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 24 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $24 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -1 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 4,455 | N/A | N/A | N/A | N/A |
| End Cash Position | 4,027 | N/A | N/A | N/A | N/A |
| Net Cash Flow | $-428 | $N/A | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -451 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -451 | 0 | 0 | 0 | 0 |